On January 11, 2024, Jonathan Lanfear notified the Board of Directors (the Board") of Molecular Templates, Inc. (the Company") of his decision to resign from the Board and as a member of the Board's Audit Committee, effective as of January 11, 2024. Effective as of Mr. Lanfear's resignation, the Board appointed director Kevin Lalande to the Audit Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | -.--% | -2.40% | -67.29% |
May. 15 | Earnings Flash (MTEM) MOLECULAR TEMPLATES Posts Q1 Revenue $11.1M | MT |
May. 15 | Molecular Templates, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.29% | 8.03M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- MTEM Stock
- News Molecular Templates, Inc.
- Molecular Templates, Inc. Announces Board Changes